Inlexisertib; DCC-3116
Product Detail
Khoom cim npe
Pob Loj | Muaj | Nqe (USD) |
Lub npe tshuaj:
4-(3-((2-((2-ethyl-4-(4-methylpiperazin-1-yl)phenyl)amino)-5-(trifluoromethyl)pyrimidin-4-yl)amino)propyl)-1,4 -oxazepan-5-ib
SMILES Code:
O=C1CCOCCN1CCNC2=NC(NC3=C(CC)C=C(N4CCN(C)CC4)C=C3)=NC=C2C(F)(F)F
InChi Code:
InChI=1S/C26H36F3N7O2/c1-3-19-17-20(35-12-10-34(2)11-13-35)5-6-22(19)32-25-31-18-21( 26 (27, 28 29) 24(33-25)30-8-4-9-36-14-16-38-15-7-23(36)37/h5-6,17-18H, 3-4,7-16H2 , 1-2H3, (H2, 30, 31, 32, 33)
InChi Key:
CNBTYICEJGEABG-UHFFFAOYSA-N
Lo lus tseem ceeb:
2543673-19-2; CAS: 2543673-19-2; CAS: 2543673-19-2; DCC3116; DCC-3116; DCC 3116; Inlexisertib
Solubility:
Cia:Qhuav, tsaus thiab ntawm 0 -4 C rau lub sijhawm luv (hnub mus rau lub lis piam) lossis -20 C rau lub sijhawm ntev (hli mus rau xyoo).
Nqe lus piav qhia:
DCC-3116 yog qhov ncauj qhov ncauj ULK1/2 inhibitor.
Hom phiaj: ULK1/2